Does the Institute for Clinical and Economic Review Revise Its Findings in Response to Industry Comments?

Cohen, Joshua T; Silver, Madison C; Ollendorf, Daniel A; Neumann, Peter J

Cohen, Joshua T; Silver, Madison C; Ollendorf, Daniel A; Neumann, Peter J.

Afiliación

Cohen JT; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA. Electronic address: jcohen@tuftsmedicalcenter.org.
Silver MC; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.
Ollendorf DA; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.
Neumann PJ; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.

Value Health ; 22(12): 1396-1401, 2019 12.

Article en En | MEDLINE | ID: mdl-31806196

Asunto(s)

Academias e Institutos/normas; Industria Farmacéutica/métodos; Quimioterapia/economía; Análisis Costo-Beneficio; Costos de los Medicamentos/estadística & datos numéricos; Humanos; Modelos Económicos; Estados Unidos

Palabras clave

ICER; cost-effectiveness; health technology assessment; value frameworks

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Industria Farmacéutica / Quimioterapia / Academias e Institutos Tipo de estudio: Diagnostic_studies / Health_economic_evaluation / Health_technology_assessment / Prognostic_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Año: 2019 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google